A variety of tumors including glioblastoma, prostate cancer, breast cancer, lung cancer, melanoma, and digestive system cancer are associated with the inactivation of PTEN (Furnari et al., 1997; Myers et al., 1997; Maehama and Dixon, 1998; Zhang et al., 2004). This evidence concerns the gene PTEN and lung carcinoma.